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ABSTRACT: A dynamic plantwide model was developed for the synthesis of the Active 
Pharmaceutical Ingredient (API) ibuprofen, following the Hoescht synthesis process. The kinetic 
parameters, reagents, products and by-products of the different reactions were adapted from 
literature, and the different process operations integrated until the end process, crystallization and 
isolation of the ibuprofen crystals.  The dynamic model simulations were validated against available 
measurements from literature and then used as enabling tool to analyze the robustness of design 
space. To this end, sensitivity of the design space towards input disturbances and process 
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uncertainties (from physical and model parameters) is studied using Monte Carlo simulations. The 
results quantify the uncertainty of the quality of product attributes, with particular focus on crystal 
size distribution and ibuprofen crystalized. The ranking of the most influential parameters on the 
chosen quality attributes is presented, with crystal growth and water concentration being the most 
influential ones. The total amount of saturated solvent, which propagates from upstream processes, 
has been shown to highly influence the total mass of crystal produced, and the underspecified API 
as well. This dynamic plantwide modeling coupled with Monte Carlo simulations is valuable to 
improve design and optimization of pharmaceutical processes at early stages, especially to 
bottleneck the design space against a range of uncertainties and disturbances. 
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 1. Introduction 
The pharmaceutical industry is continuously under pressure. While the competition with generic 
drug manufacturers is as fierce as ever, regulations are increasingly strict, and growing awareness 
that drug manufacturing can have a significant environmental impact leads to growing demand from 
the consumers to environmentally friendly pharmaceutical production, or greener products 
[1,2]
. In 
addition, development costs for new drugs are somewhere between a couple of hundreds of 
thousands of dollars to a few billions 
[3,4]
, and this cost value has been shown to steadily annual 
increase
[5]
. Facing these conditions, and with a fixed patent lifetime, modern pharmaceutical 
industry needs to make an effort in evolving towards more efficient and innovative production 
processes.  
This has been particularly stressed by the U.S. Food and Drug Administration (FDA), with the 
introduction of Process Analytical Tools (PAT) concept
[6]
. Within the referred document, the FDA 
encouraged the usage of different tools for process understanding, design space exploration, and 
online monitoring and control. Special emphasis was given to the use of multivariate tools for 
design, data acquisition and data analysis. As defended by other studies
 [2]
, Process Systems 
Engineering (PSE) methods are critical for these achievements, and these methods have been 
broadly used by other industries (petrochemical and polymer industry for example)
[7]
, as well as 
increasingly applied by bio-based industries
[8]
. Whether the objective is to evaluate and improve an 
existing API synthesis process, or study and analyze different operability spaces and/or different 
flowsheet hypothesis, many PSE methods have been studied and improved over time
[2]
. For 
instance, different authors developed tools for the generation and evaluation of different 
pharmaceutical process designs with ecological considerations 
[9-11]
. By integrating these with 
component’s physical properties databases, pollution prevention is focused from the early stages of 
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process development and intensification, instead of focusing in waste treatment solutions at the end 
of the process.  Furthermore, through the application of mechanistic models it has been shown that 
continuous pharmaceutical manufacturing can achieve low environmental footprints
[12]
 and, as 
demonstrated, the continuous manufacturing of an API can achieve lower total costs, when 
compared to batch production of the same components
 [13,14]
. Addressing uncertainties in the 
process, either by a mechanistic model description or experimental approaches 
[15,16]
, enables 
probabilistic risk analysis. This allows a process engineer to understand the chances of not 
achieving the critical quality attributes (CQA) of a certain process, i.e., the scenario of failing to 
meet target design specs and/or the scenario of being below the target process economic metrics 
(e.g. certain net present value, as demonstrated elsewhere
[17]
). The study of the possible scenarios 
helps in long term operation planning and to make solid and decisive decisions when the whole 
process/market is uncertain. Different studies and efforts have focused on methodologies 
[18]
 and 
tools to help and support such cases, while addressing economic and ecological objectives 
[11, 19]
, 
and including future possible changes in the regulatory policies for waste management and 
treatment 
[19]
.
 
Further including sensitivity analysis, either local or global 
[15,20]
, is definitely 
essential for experimental design and focus of collecting critical missing or misleading data. In 
addition, the identification of most the influential parameters of a system is beneficial for the 
implementation of new and more advanced control strategies. These strategies gained a new focus 
in the past years in the pharmaceutical industry, with downstream hybrid MPC-PID control 
implementations to reduce the final product off-spec due to upstream disturbances/uncertainty
[21]
, 
model predictive control of complex batch processes (such as crystallization)
[22-24]
, amongst others. 
One API in particular has had quite the attention from academia in the past years: Ibuprofen (2-
(4-isobutylphenyl) propionic acid). This commonly known analgesic was considered an essential 
drug by the World Health Organization in 2009, even thought it was first synthetized by Boots in 
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the 1960s. The Boots synthesis method was overcome by the Hoechst process, which reduced the 
number of synthesis steps from six to three. Although nowadays there are more efficient synthesis 
routes
[25]
 and efforts are being made to show that moving from batch production to continuous is 
viable 
[14,26]
, much of the on-going industry still relies on the Hoechst batch process. However, and 
to our best knowledge, there has been no focus in studying the design-space of the upstream 
synthesis, even though that data and reaction kinetic studies have been published in some of the 
synthesis steps, taking into consideration the choice of catalysts, process pressure and temperature 
[27-29]
.  
 In this work, the objective is to develop a dynamic plantwide model for simulation, uncertainty 
and sensitivity analysis of the upstream process of ibuprofen through the Hoechst synthesis path. 
The dynamic flowsheet model is based on the available data regarding the process, and the 
operability space of each individual model is the same as the published one. Several assumptions 
were made, regarding some intermediate properties and purification steps. The design space is 
explored through a sensitivity analysis and error propagation performed on parameters such as each 
model temperature, pressure and pH. After exploring the impact they have further downstream, a 
detailed population balance cooling crystallization model is included. A global sensitivity analysis 
and Monte Carlo based nonlinear error propagation of upstream process parameters, models 
parameters and physical parameters is then applied, and deviations in the crystal size distribution 
and crystal produced are ranked accordingly to the influence from the input analysis. The outcome 
opens the to further plantwide control implementation, and directs towards experimental design. 
This paper is organized as follows: first the case study and methodology is presented in the 
material and methods section. The methodology consists of : (i) model collection and analysis, (ii) 
flowsheet assembly and dynamic simulation, and (iii) Uncertainty and sensitivity analysis. In the 
results and discussion section, first model validation results for selected unit operations are given  
Page 5 of 38
ACS Paragon Plus Environment
Industrial & Engineering Chemistry Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
followed by model integration and dynamic simulation results for cyclic steady state. These are 
followed by local sensitivity analysis in the upstream synthesis of the process parameters to study 
influence of process parameters. Finally global uncertainty and sensitivity analysis results obtained 
from crystallization process are presented to assess the impact of error propagation on the critical 
attributes of product. The paper ends with concluding remarks and perspectives. 
 
2. Material and methods 
The ibuprofen synthesis case study is based on the Hoescht path
[30],
 which consists of three main 
reaction steps: Friedels craft acetylation of isobutylbenzene into 4-isobutyl acetophenone (IBAP), 
hydrogenation of IBAP into 1-(4-isobutylphenyl)ethanol (IBPE) in the presence in the presence of a 
catalyst, and carbonylation of the produced IBPE into ibuprofen and by-products in the presence of 
a catalyst. In this work, as no data has been found for the first reaction, IBPA is assumed to be the 
initial reagent in this chain. The referred process steps are discontinuous, and were assumed occur 
in isothermal conditions and in perfectly mixed batch vessels. 
 
 
2.1. Model collection and analysis 
 
The reaction kinetics, solvents and by-products are adapted from elsewhere
[28]
 for the 
hydrogenation synthesis: 
 = −
, == ,()         (1)  !"# = 
, − 
,$ == 
, − %&',$ !"()$(1 + , !- !- + ,()$ +,)$.)$.)$ (2) /012# = 
,3 == %&',3 !-$(1 + , !- !- + ,()$ + ,)$.)$.)$ (3)  !"!# = 
,$ (4) & = 4(56789: ) (5) 
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where CIBEB represents the molar concentration of the by-product 4-isobutylethylbenzene (IBEB)  
and CH20 represents the molar concentration of water. Water formation is proportional to the second 
reaction (eq.4). Rate and equilibrium constants are used after the same work: 
',1(;) = ',1(;<)4(5=>?,9@ AB5 B<C)   (6) 
 
The kinetics, solvents and by-products for the carbonylation step are also adapted from 
literature
[29]: 
 = = −
%, =	−'%, !")                                                           
                               
(7) 
E = 
%, − 
%,$ + 
F,5$ = 	
F, − 'F,$ !G)05 +	'F,5$ !0                  
                        
(8) 
 !0# = 
F,$ − 
F,5$ + 
F,3 = 
F,$ − 
F,5$ − 'F,3 !0C%,)$.C.%,%
I.K3
1 + ,% !0  
 
(9) 
LM7? =	
%,3     (10) 
                                                                                                         
where CIBS, CIBPCl, Cprod and CIBPE represent respectively the molar concentration of 4-iso-
butylstyrene (IBS), the molar concentration of 1-(4-iso-butylphenyl)ethyl chlorine (IBPCl), the 
molar concentration of the end-products IBU and 3-(4-iso-butylphenyl)propionic acid (3-IPPA), 
and the molar concentration of IBPE. The carbonylation kinetic parameters are calculated by 
equation 11, and the concentration of carbon monoxide dissolved (CCO) is calculated through 
equation 12: 
'%,1 = 'I,145",9N∗;  (11) 
/ = (%/PQ              (12) 
 
where Pco is the partial pressure of CO, and He is the Henry’s constant of CO in a mixture of 
IBPE and  the reaction’s solvent, methyl-ethyl-ketone (MEK). The dependence of He with the 
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weight ratio of IBPE in MEK and the mixture temperature has been reported
[28]
. A linear model was 
used to generate the He values depending on the IBPE mass ration and the process temperature, and 
can be consulted in Supporting Information (section A). 
 
The model used for the ibuprofen cooling crystallization is a population balance model based on 
the method of classes, adapted from elsewhere 
[31]
. For a two dimension crystallization problem, the 
number of elements (N crystals) in in the i
th
 class of the first characteristic length and in the j
th
 class 
of the second characteristic length is described as: 
R1,S# + T1,S − T1,S" = VWX%	1,S − Y1,S (13) 
 
 
where f and f” represent the inflow from and outflow to adjacent classes, Bnuc is the term of birth 
(newly formed crystals due to nucleation) and D commonly stands for term death of crystals 
(phenomena in the crystallization that include breakage of the crystals). The inflows and outflows 
of the adjacent classes are illustrated by the equation (14). 
T1,S = Z[,15R15,S2 ∗ [(15) + Z],S5R1,S52 ∗ ](S5)  (14) 
 
 
where Cx and Cy represent the discretization space, or the classes. The growth kinetics of 
ibuprofen in an aqueous-ethanol solution are adapted from elsewhere 
[32-34]
.  Equations 15 to 19 
represent, respectively, the growth value of crystals, the super-saturation curve, the saturation 
profile, the temperature inside the crystallizer and the temperature of the cooling serpentine: 
Z1 = '1^_W (15) 
_^ = max	(0, 1dX − __ ) (16) _ = 0.495 + 0.001026i%j]_$ (17) 
i%j]_# = −kP%l%mn/jo,%j]_ − pq(i%j]_ − ir)l_/0mst,_/0  (18) 
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ir# = ur,1WlrQjst,rQj(ir,1W − ir) + pq(i%j]_ − ir)lrQjmrQjst,rQj  (19) 
 
Where ∆Hc is the enthalpy of crystallization, ρc the crystal density, Vform,cryst is the volume of 
newly formed crystal, ρsol is the density of the solution, cp,sol is the specific heat capacity of the 
solution, V is the solution volume, Fw,in is the inflow of cooling water in the cooling serpentine, 
ρwater is the density of water, cp,water is the specific heat capacity of water, Tw,in is the inlet temperature 
of the cooling water, U is the Heat transfer coefficient of the crystallizer wall, and A is the surface 
area of the cooling serpentine. Values were taken from literature
[23,35]
. The temperature within the 
crystallizer, Tcryst, depends on the cooling profile imposed to the cooling serpentine, Tw, by changing 
the temperature of the water inflow. The water inflow temperature was assumed to be composed of 
two profiles, described by equation (20): 
 
vwx
wy io[ − #	(io[ − i01W)#01WQj ,																														# < #01WQj
i01W − (i01W5i{|}) ~ # − #01WQj#o[ − #01WQj
. , # > #01WQj 
(20) 
where Tmax  is the initial temperature of the crystallization, Tlin is the end temperature of the linear 
decrease, tlinear is the time of linear decrease, Tmin is the end temperature of the crystallization, and 
tmax is the total duration of the crystallization. The remaining assumptions done for the 
crystallization can are present in the Supporting Information (section B). 
Both reaction models (carbonylation and hydrogenation) where compared against the published 
data from the same authors 
[28,29]
. This was done by fitting the parameters to the data reported 
minimizing the sum of the squared errors, and verifying if the estimated value would coincide 
within the 95% confidence interval reported. If the estimated parameters fit within the reported 
intervals, no further work is performed on the model, and the reported parameters are used for the 
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upcoming tasks. However, if this is not the case, a parameter estimation, identifiability analysis and 
uncertainty analysis are performed.  
- For the parameter estimation, the methodology follows the workflow of Sin et al.
[36]
, using the 
maximum likelihood estimation method from Seber & Wild 
[37]
 where the covariance matrix 
COV(θ), can be estimated by eq. 20: 
m(θ) = (θ)R −  (	(θ);o5 ~θ) (20) 
(θ) = arg 	(1Q[t − 1tjQ)$1  (21) 
Where J(θ) is the minimum sum of squared errors obtained from the least-squares parameter 
estimation (eq. 21), 
]θ is the sensitivity matrix of the model variables (y) to the parameters 
(θ), Qm is the covariance matrix of measurement errors, and N and p are the total number of 
measurements and the total number of estimated parameters, respectively. The correlation 
between two parameters is then calculated as it follows: 
(θ , θr) = m(θ , θr)θ$ θ$  
(22) 
 
- For identifiability analysis, the two step procedure of Brun and co-workers
[38]
 as described in 
Sin. et al.
[36]
 was used. The identifiability method ranks the parameter significance, δ
msqr
, and 
a collinearity analysis, Υk, are obtained though eqs. 23-26: 
δ
o_j = 1R 
11  
(23) 
 =	 1min	(λ) (24) 
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λ = 44(
;
) (25) 

 = 
‖
‖ (26) 
 
where sr is the vector of non-dimensional sensitivity values, K a parameter subset, λK is the 
eigen values of the normalized sensitivity matrix for parameter subset K, and snorm is the 
normalized non-dimensional sensitivity function using Euclidian norm. The collinearity index 
is used to find an appropriate subset of parameters with a value between 10 and 15, as largely 
used in literature 
[38,36]
 
-
 The uncertainty analysis performed is based on the well-defined Bootstrap method 
[39]
, and 
the methodology can be found in the work of Frutiger et al.
[40]
. 
  
 
 
2.2. Flowsheet assembly and dynamic simulation 
 
In order to simulate the dynamic behavior of the ibuprofen synthesis, the previous described 
models are integrated. To connect the discontinuous (batch type) unit processes with the 
continuously operated operations, several simplified models were included, such as buffer tanks 
(before and after each major process step), a simplified decanter for the reaction steps (based on 
available information 
[30]
), and assumed distillation fractions based on predicted boiling points of 
the involved components (the boiling points were obtained using Group-Contribution based 
property estimation method 
[41]
). The predicted values are presented in Supporting Information 
(section C, table S.2).  
The holdup within the buffer tanks is described by equation (27). The valve values change 
between 0 and 1, depending on the operating phase of the previous or following unit operation. For 
instance, the outlet valve of the buffer tank preceding the hydrogenation step follows equation (28): 
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m1# = &41W,1u1W,1 − &4/X,1u/X,1 (27) 
&4/X,tjQ5%j]_ 1, #/tQj1/W < #]j/2QW1/W	jQ%1/W 	 # > #n1001W2	]	jQ%/j 	0, #¡4
¢4  
(28) 
 
toperation is a cyclic value between 0 and the sum of the emptying time, filling time and reaction 
time of the respective operation. The value resets to 0 when the max value is achieved. The 
integration was performed in a Matlab/Simulink interface (The MathWorks
®
, Natick, MA), divided 
in three steps: 
• The first step is resumed into the user input: this is performed in Matlab, where the initial 
conditions, batch time, emptying and filling time, and process parameters are chosen. Process 
understanding is the most important key in this part, as a huge number of possibilities exist for 
process input. However, the user needs to pay close attention to the feasibility of those choices. 
One common example, is the constant increase in the tanks holdup content, or running dry; 
• The second step is performed within Simulink, where the simulation occurs until the filling of 
the crystallizer. This is due to the fact that for the simulation of the initial models a fixed step 
solver was found to give a faster result (ode4 Runge-Kutta). The results are saved and sent to 
the third step;  
• The third step is simulation of the ibuprofen crystallization. Extra inputs from the user are 
requested, such as the initial seed mass and size characteristics, and the cooling profile. Ode15s 
is the solver used for this population balance model. 
 
The dynamic flowsheet model implemented in Matlab Simulink is displayed in figure 1. 
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Figure 1 – Dynamic flowsheet model implementation in Matlab Simulink 
 
 
 
 
2.3. Uncertainty and sensitivity analysis  
Cyclic-steady state is reached globally, with each dynamic state being periodic. Hence, the 
design space can be studied with disturbances to the system, and the weight of those disturbances 
analysed. Therefore, local sensitivity analysis was performed by changing key parameters, one 
factor at a time, in accordance to other authors 
[15]
. These are available in Supporting Information 
(table S.3, section D), together with the deviation from the initial value. The propagation of the 
deviation is then carried out to the final crystallization model. Here, uncertainty analysis and global 
sensitivity analysis were performed. For uncertainty analysis, we used the engineering standard 
technique of Monte Carlo method
15]
, consisting of three steps: (1) specifying input uncertainty, (2) 
sampling input uncertainty, and (3) propagating the sample input uncertainty through the model, 
obtaining different output vector.  
(1) The input uncertainty was defined as a uniform distribution centralized in the 
parameter mean, θmean, with maximum and minimum values being calculated as follows: 
θo1W = (1 −%m&
&#) ∗ θoQW (29) 
θo[ = (1 +%m&
&#) ∗ θoQW (30) 
 
(2) The probabilistic sampling of the input, Latin Hypercube Sampling was used
[42]
, 
with 300 samples from the input space defined in (1). No correlation was assumed for the samples, 
as no previous information was available.  
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(3) The propagation of the sampling space through the dynamic model was done over 
the 5 hours crystallization, with data collected every minute (300 points) for the CSD. The 
uncertainty of the model outputs for the final simulation time is represented with mean and 95% 
confidence interval. 
For global sensitivity analysis we used linear regression of Monte Carlo outputs, so called 
Stadardised Regression Coefficients (SCR). The scalar model output matrix can be denoted as sy 
and has the dimension of K*N, where K is the number of output variables and N the number of 
samples. The regression model is then fitted to the scalar output of the Monte Carlo simulations 
relating model output, sy to the model inputs considered in the uncertainty analysis, θij as shown in 
equation (31): 
1 = ¤I +¤Sθ1S + ε1¥S¦  
(31) 
 
Where syik is the scalar value for the k
th 
output, bjk is the coefficient of the j
th
 input parameter, θj, 
for the k
th
 output, θij is the value of the j
th
 parameter and εik is the error of the regression model. 
Equation (30) is then written in dimensionless form by scalling the outputs and the parameters using 
their corresponding mean and standard deviations 
[43]
 as expressed in equation (32): 
1 − μ_]¨_]¨ =©S
θ1S − μθªθª
¥
S¦ + ε1 
(32) 
 
The standardized regression coefficients, βjk, can range from [-1 1]. A negative sign represents a 
negative effect in the output, and vice-versa, and its magnitude defines the influence of the input on 
the model output.  
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3. Results and discussion 
 
Model Validation. The data fitting of the hydrogenation parameters agreed with the results 
presented by Thakar et al.
[28]
, and can be observed in figure 2. The estimated parameters were 
obtained through a minimization of the squared errors between the reported data and model 
predictions. As the new estimations are within the reported confidence interval, no further work is 
performed. The results can be observed in table 1.   
Table 1 – Comparison between reported and calculated kinetic parameters for hydrogenation 
Parameter Reported values Estimated values 
 Values at 95% 
confidence interval 
-95% +95% 
kh,1 L/(gcat atm s) 1.14 0.89 1.39 1.22 
kh,2 L/(gcat atm s) 0.095 0.075 0.115 0.088 
kh,3 L
2
/(gcat atm s) 0.024 0.020 0.028 0.021 
KIBAB L/mol 76.4 52.7 100.1 69.5 
KH2O L/mol 529 420 635 634 
 
However, there was a full disagreement with the reported values in literature
[29]
, for the 
carbonylation of IBPE. This mainly due to the lack of understanding of the initial concentration for 
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the hydrochloric acid. Assuming a constant concentration of hydrochloric acid (HCl) of 0.24 mol/L 
and 2.67mol/L of water, a parameter re-estimation, identifiability analysis and uncertainty analysis 
was performed for the carbonylation process. 
 
 
Figure 2 – Comparison between the reported experimental values at 373K 
It can be observed in table 2 that the available data
[29]
 is not information-wise rich enough to 
obtain a unique set of kinetic parameters values that represent the system, using the model presented 
in equation (7-11). In fact, the correlation matrix in Supporting Information (table S.4 section E) 
shows that there is a huge correlation between the kinetic parameters and their respective activation 
energies.  
 
Table 2 – Parameter fitting from the carbonylation literature 
 Eac,1 Eac,2 Eac,-2 Eac,3 k0,1 k0,2 k0,-2 k0,3 Kc 
Units kJ/mol kJ/mol kJ/mol kJ/mol L/(mol.
s) 
L
2
/(mol
2
.s) L/(mol.s) L
2.43
/(mol.
2.
43
.s) 
L/(mol) 
Estimated 
value 
21.43 43.51 35.52 35.14 6.07 1.38E+04 1.52E+02 1.64E+05 26.57 
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σ 2.50 21.77 66.42 4.82 4.71 9.34E+04 3.13E+03 2.48E+05 14.26 
-95% 16.46 0.24 -96.50 25.56 -3.29 -1.72E+05 -6.07E+03 -3.29E+05 -1.78 
+95% 26.41 86.77 167.54 44.72 15.426 1.99E+05 6.38E+03 6.56E+05 54.92 
 
Following the methods for identifiability analysis described prior to this section, the ranking of 
the parameter significance can be observed in figure 3.  
Apart from the IBPE plot (which is only influenced by eq. (7) activation energy and reaction 
rate), it can be observed that the activation energies have the most impact in the outcome of the 
system. This has been taken into consideration when choosing a suitable subset (out of 502 possible 
combinations) for a new parameter estimation. Regarding the collinearity analysis, subsets 
consisting of 5 parameters in which 4 are the activation energies, are within the gap used in 
literature
([38, 36])
. 
 
Figure 3 – Parameter significance ranking for the carbonylation model 
 
However, the correlation and uncertainty obtained was still non-reasonable and very high. The 
subset consisting of the 4 activation energies was then selected for the new parameter estimation, 
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and for uncertainty analysis using the Monte Carlo method with Bootstraps sampling. The 
Bootstraps sampling was performed 200 times from the data residuals, (correlation matrix and 
sampling results available in Supporting information, tables S.4 and S.5 and figure E.1, Section E). 
The newly estimated values for the activation energies are shown in table 3, together with the 
reported values from literature
[29]
, and the model outputs, confidence intervals and available 
experimental data are presented in figure 4. 
The model output recreates with high precision the experimental data published by Seayad et 
al.
[29]
. With the exception of the end of reaction concentrations for the resulting products (IBU and 
IPPA, and IBS) most of the points are caught within the confidence interval of the carbonylation 
model.  
Table 3 – Parameter re-estimation and comparison with reported values from literature  
 Chaudhari et al.[24] New estimation 
Reported value σ Estimated value σ 
A
c
ti
v
at
io
n
 e
n
er
g
ie
s 
(k
J/
m
o
l)
  
Ea1 64.35 - 21.77 0.06 
Ea2 49.49 - 43.62 0.40 
Ea-2 79.39 - 34.72 1.01 
Ea3 89.08 - 33.86 0.10 
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 Figure 4 – Comparison between model predictions obtained using newly improved parameter 
estimation and the experimental data at 388K 
 
Dynamic simulation - Together with the hydrogenation step, carbonylation has been 
implemented into model flowsheet. IBAP is fed to the MIXER 1 unit with n-Decane and Pd/SiO2 as 
the solvent 
[28]
. The final concentration of IBAP was set to be 0.27 mol/L and the catalyst 0.5 g/L. 
For the tanks preceding the hydrogenation reactor (Tank Pre-Hydrogenation) the initial 
concentration is set to be the same as the cyclic steady-state feed, which in this case is the same as 
the outcome from the MIXER 1 unit. The tank is set with an initial holdup enough to cover a full 
upcoming operation. The same strategy is applied to remaining tanks, where the initial composition 
of these units that follow a reactor is the same as the expected from a cyclic-steady state (no 
disturbances). The hydrogenation reactor is set to the same operation conditions as reported by 
Thakar et al., with a constant hydrogen partial pressure of 20 bar, at constant temperature, 373K. It 
is assumed perfect mixing, and inexistent mass transfer limitations between gas-liquid. The reaction 
occurs for 25 minutes before emptying the reactor, re-filling, and repeating the process.  
For the first separation process, it was assumed that the formed oligomers and catalyst were 
perfectly separated. As reported in table S.2 in the Supporting Information, the predicted boiling 
point of IBEB was the lowest on from the hydrogenation compounds. Thus it was assumed to be 
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perfectly separable. A fixed recovery of 98% of IBPE was set, with 95% molar purity. The 
remaining fraction was divided according to the feed ration for the remaining components. This 
outlet is then mixed with a fresh feed of MEK, HCl, water and the second homogeneous catalyst 
(PdCl2(PPh3)2/PPh3 
[29]
. The amount mixed ensures the pre-carbonylation IBPE concentration of 
1.13 mol/L, water concentration of 2.67 mol/L, and HCl concentration of 0.24 mol/L. The 
carbonylation reactor operates at 54 bar, constant temperature of 388K, for 90 minutes. IBAP does 
not react within this operation.                                           
The second separation step assumes a set of different steps, as aqueous/organic separation and 
distillations. For the aqueous/organic separation, it is assumed that the separation is ideal, and the 
remaining HCl and catalyst is removed together with the water from the process. The assumption 
for the second separation step is different than the separation process 1. Three outlet streams are the 
result of this step, recreating a light Key stream, medium Key stream and heavy Key stream flows. 
Table 4 shows the outlet/feed ratio assumed for the different components in the outlet streams. 
Table 4 – Assumed outlet ratio for the second separation step 
Outlet/feed 
ratio 
MEK IBPA IBAP IBS IBPCl IBU 3-IPPAP 
Light key 1 0.998 0.998 1 0.999 0.02 0 
Medium key 0 0.002 0.002 0 0.001 0.96 0.20 
Heavy key 0 0 0 0 0 0.02 0.8 
 
The cooling crystallization operates for a total of 5 hours, with a starting temperature of 32, a 
constant decrease until 28, and an end temperature of 11. The time for the linear decrease of 
temperature (Tlinear) was set to be 30 minutes.  
Figures 5, 6 and 7 show the cyclic steady state achieved for the upstream synthesis of Ibuprofen. 
The tank levels start in cyclic steady state. The difference between the minimum and maximum 
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holdup level achieved for each one is due to the differences in filling and emptying time. This is due 
to the fact that one of the valves is always open, and continues to empty (in case of following a 
reactor) or continue to fill (for reactors preceding the reactors). 
The profiles of the reactors mimic the results obtained from literature
[28, 29]
. The results presented 
are shown in different time scales in order for better understanding and visualization. The steady 
concentration of the components within the end of each separated batch can be observed. During 
this time, the reactor is emptying, and the concentration values do not change. In contrast, when the 
filling process starts, there is an abrupt change in the concentrations due to the feed of solvent not 
containing any product (IBPE/IBEB for the hydrogenation step, and IBU/IPPAP for the 
carbonylation). After a brief stabilisation, the process restarts. 
 
 
Figure 5 – Dynamic behaviour of the buffer tanks before and after the main reactions carbonylation 
(left) and hydrogenation (right) 
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 Figure 6 – Dynamic behaviour of hydrogenation and carbonylation reaction 
 
The ibuprofen cooling crystallization occurs with secondary nucleation. As it can be observed 
after 5 hours of crystallization, a small amount of crystal is formed and accumulated near the first 
classes (Xsize and Ysize tending to zero). The effect of a small growth constant for ibuprofen crystal 
in ethanol/water concentration can be observed on figure 8 (left). Although the temperature closely 
follows the inlet temperature of the cooling serpentine, the gap between the saturation concentration 
and the solute slowly converges.  
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 Figure 7 – Ibuprofen solute concentration and saturation profile over the 5 hours 
crystallization(left), and CSD of ibuprofen crystal after 5 hours crystallization (right). 
The cyclic steady state obtained from the resulting simulation achieves a steady production of 
approximately 48.1 kgs of ibuprofen per crystallization batch. The final solute concentration is 
approximately 0.70 kgibu/kgsolvent, higher than the saturated concentration at 12°C. This is due to the 
slow growth of the API.  However, part of the crystalized API does not meet the requirements 
assumed for this process (150 µm for the x characteristic length, and 70 µm for the y characteristic 
length). Roughly 3.14 kgs of the total mass of crystal does not have the minimum size attributes to 
be considered valid for downstream processing.   
 
Local sensitivity analysis - Figures 8 and 9 show the dynamic behaviour of the upstream 
synthesis of ibuprofen with continuous disturbances, on key process variables. These disturbances 
were introduced 5 minutes after the simulation start. The relative deviation to the initial case can be 
seen in table S.6, Supporting Information (section F). The effect of these disturbances propagates 
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from process to process, as no control is implemented. It is also noticeable the time delay from 
batch to batch, as the whole process takes considerable time until reaching the new steady state. 
Changes in pressure and temperature are instantaneous in the respective reaction process, but are 
slowly propagated downstream through the process.  
As the purity fractions were assumed and no data is provided related to the co-crystallization of 
IPPAP, no further analysis has been done regarding the ppm of this by-product in the crystallizer. 
 
Figure 8 – Changes in IBPE and IBEB (left), and changes in IBPE and IBU (right) in response to 
temperature changes in hydrogenation reaction. 
 
The most influential process variables are the temperatures. Within the range of 10 degrees, 
ibuprofen final concentration ranges from 1.7% to -4.5% (based on reference case), per percent 
point variation within the temperature. This effect is peculiar in the hydrogenation temperature. 
Both changes decrease the overall synthesis of Ibuprofen, because the initial reagent IBPE is 
converted in higher amounts to the non-desired by-product, IBEB. 
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 Figure 9 – Changes in IBPE and IBU concentration profiles in response to the temperature changes 
in carbonylation reaction (left) and in IBPE and IBEB due to catalyst concentration changes (right) 
Figures 10 and 11 show the evolution of the main hydrogenation products (IBPE and IBEB) over 
time, over different temperature profiles. It can be observed that the hydrogenation step does not 
operate in its optimal temperature for the provided reaction time (25 minutes). However, this opens 
a space of decisions for a possible process engineer: it is possible to achieve the same or even 
higher final concentration of IBPE in lower time, while operating the process at higher 
temperatures. The downside is that the optimal region for stopping the reaction is smaller, and 
mistakes in the scheduling can propagate huge errors: lower final concentration of IBPE and higher 
undesired amounts of IBEB. On the other side, this time interval for stopping the reaction is bigger 
if the temperatures are lower. This comes with the cost of more operating time. 
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 Figure 10 – Effect of temperature on IBPE concentration profiles over time, in the hydrogenation 
reaction. The dark lines represent the sensitivity cases simulated. 
 
Figure 11 –Effect of temperature on IBEB concentration profiles over time, in the hydrogenation 
reaction. The dark lines represent the sensitivity cases simulated. 
 
Global sensitivity analysis - With the deviation from the upstream processes, and uncertainty 
available from literature, Standardized Regression Coefficients (SRC) method was applied to the 
crystallization process. Monte Carlo coupled with Latin hypercube sampling was used for 
simulating the possible input space. The list of input uncertainties is shown in table 5. Although that 
water was considered to be totally separated from the carbonylation process, and carefully added 
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before the crystallization, the sensitivity performed will take into account possible deviations, in 
preparation for further work. It was assumed that the uncertainty in water is huge, ranging from 
90% less to 90% more from the initial case. Thus, the total mass of saturated solvent (aqueous 
ethanol), time duration of the linear decrease of temperature and water concentration were 
considered for the sampling process, as well as other parameters. For the sampling step, we 
performed 300 random samples using Latin hypercube sampling technique from multivariate input 
space, as defined in Table 5. The samples are shown in Supporting Information (section G). 
 
Table 5 – Input uncertainties in crystallization process 
Parameter Units Initial value Uncertainty range (%) 
[*]
 
Solvent mass (ms) kg 55  15 
Water concentration (xw) kg/kgsolvent 0.1  90 
Linear cooling time (tlinear) min 30 50 
kb
[34] 
#/min/kgsol 5.3 65 
kg
[32]
 µm/min/Ssat 1.78e
8
 60 
Initial seed mass (mseed) kg/kgsolvent 0.05 50 
[*]
- Each input is assumed uniformly distributed with upper and lower bounds defined by a certain uncertainty range 
around the initial value 
 
The impact of the specified input uncertainty on the output is calculated on three different points 
of the CSD (on the average x characteristic length, x1, x2 and x3), chosen based on the simulations 
output (figure 13). This choice was based on the fact that x1 (65 µm) is a noticeable point of 
influence from the effect of the secondary nucleation, opposing to x3 (255 µm)  that is dependent on 
both growth and initial API dissolved. The point x2 (185 µm) is within the range of the most 
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probable mean characteristic size. In addition, the influence of the uncertainty is also taken in to 
consideration on the total mass of crystal formed, Tmass, and on the ratio of API below the desired 
size specifications, rlow_spec. 
 
 
Figure 13– Representation of the uncertainty in the crystal size distribution 
The linearization model obtained for the data on the three chosen points, APImass and rlow_spec 
verifies applicability of SRC method, as coefficient of determination is sufficiently high, R
2
>0.7 
[42,43]
. As it is shown in table 6, the parameters have different significance depending on which 
output is observed. Regarding the average population in the chosen crystal lengths, the water 
concentration, the initial seed and the crystal growth parameter are the most influential. As water 
influences both the growth and birth of the ibuprofen crystals in the solvent, the population of 
crystals with 65 µm will not increase with the decrease of growth and birth. This is due to the fact 
that secondary crystallization will yield a smaller population. In addition, the overall growth of 
crystals will be slower due to the water influence, and the small population formed will not reach 
the threshold of 65 before the crystallization is finished. The growth parameter, on the other hand, 
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shifts the final CSD to bigger sizes, reducing the final amount of particles within the range of x1. 
This works in the opposite way for the other points (x2 and x3). The amount of initial seed has an 
effect in how wide the crystal distribution will be. It has indeed an effect in the total number of 
crystal formed, however the highest influence is on the ratio of crystal underspecified. As more 
initial crystal (seed) is present in the medium, more solute can deposit and grow into bigger crystals. 
However, a huge number of seed will reduce the average growth, as the probability of a particle to 
deposit into a grown crystals is smaller, due to the huge number or particles. This is captured by the 
sensitivity analysis in the third point (x3), where a positive change in the initial feed of crystal has a 
negative outcome on the bigger crystal classes. 
In general, kb parameter has low impact on the specs of the different (points x1, x2, x3). For the 
smaller ones (x1), the impact is positive, as the increase in number of newly born particles increases 
the chances that some will reach this target size. For bigger crystals, however, this can be 
understood as competition for solute deposition (thus, growth). It can be also observed that 
changing the initial fast decrease of temperature has no effects in the long run for this process. 
Enhancing or delaying the secondary nucleation has shown to have no impact in the final results.  
Therefore the influence of tlinear can be mostly neglected. 
Lastly, by propagating the uncertainty shown above (table 5), the final mass of Ibuprofen 
crystalized has an average of 48.3 kg per batch unit, with a standard deviation of 4.4 kg. The main 
case scenario is within these values, as well within the target specifications of the crystals, with an 
average of 11.6% mass lost, and a standard deviation of 9%. 
 
 
 
 
Page 29 of 38
ACS Paragon Plus Environment
Industrial & Engineering Chemistry Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Table 6 – Standardized regression coefficients and parameter significance ranking 
Output R
2
 Ranking 1 2 3 4 5 6 
rlow_spec 0.811 
Par. mseed kg xw ms kb tlinear 
βi,j 0.64 -0.46 0.31 -0.19 0.14 0.03 
x1 
0.815 
 
Par. kg xw mseed kb ms tlinear 
βi,j -0.71 -0.42 0.32 0.19 0.11 0.08 
x2 0.703 
Par. mseed kg xw kb ms tlinear 
βi,j 0.51 0.48 0.41 -0.24 -0.12 -0.06 
x3 0.757 
Par. kg xw mseed kb ms tlinear 
βi,j 0.59 -0.42 0.42 -0.13 0.10 -0.06 
APImass 
 
0.967 
Par. ms kg mseed xw tlinear kb 
βi,j 0.85 0.35 0.25 0.17 -0.04 0.03 
 
 
4. Conclusions 
An upstream model-based synthesis of Ibuprofen, based on the Hoescht pathway, has been 
presented. The models available for unit operations have been validated using the available open 
literature experimental data, and improved further following a systematic and comprehensive 
identifiability and uncertainty analysis, which provided new parameter values with lower prediction 
uncertainty.  
The cyclic steady state is achieved with success within the model parameters and the assumptions 
made. The crystallization of approximately 48 kg of ibuprofen is achieved within each cycle. 93 
percent of the crystals (weight based) conformed with the target specifications of the crystals – 
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defined as being smaller than 150µm length, and 70µm width. Thus, per cycle, 3.4 kg of the API 
are not taken into account for further downstream processing. 
It has been shown that the most influential process parameters are the operating temperatures in 
both reactors. While greatly influencing the target ibuprofen production and by-products synthesis, 
further work needs to be done regarding the difficulty of separating the by-products, within their 
wide design space. Future work will focus on detailed modelling of separation processes and 
propagation of impurities from recovery step to purification of ibuprofen. 
The Monte Carlo sensitivity analysis performed in the crystallization unit has shown that the 
uncertainty provided in literature has a huge impact in the whole possible outcome of this process. 
Furthermore, one of the most uncertain parameters, kg, is also one of the most influential attributes 
in the spectrum of the CSD and total API produced. Other influential parameters include the initial 
seed mass, and water concentration in the process. These parameters can easily be controlled, and 
indeed current work is focusing on the development and validation of a nonlinear control strategy 
on laboratory scale to reject the identified process disturbances on ibuprofen crystallisation process. 
Overall the dynamic flowsheet modelling platform is demonstrated as a valuable enabling tool to 
systematically integrate knowledge about different unit operations in a form of model, perform 
systematic and comprehensive error propagation as well as sensitivity and uncertainty analysis for 
verifying the robustness of pharmaceutical manufacturing processes.     
 
Supporting Information 
Additional content and tables as noted in the text. This information is available free of charge via 
internet at http://pubs.acs.org/. 
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